Ciempozuelos

Researchers are evaluating a digital tool designed to monitor and detect early signs of relapse in addiction treatment. The study compares the traditional multidisciplinary treatment model against the same model enhanced with this digital technology. The goal is to demonstrate the added clinical value of the tool in improving long-term recovery outcomes for individuals with substance use disorders. Participants receive a comprehensive treatment that includes phases such as initial assessment, detoxification, withdrawal management, psychological and psychiatric therapy, rehabilitation, and follow-up care. One group receives the standard multidisciplinary treatment, while the other group uses a mobile application alongside standard care. This app monitors clinical signs, detects early relapse risks, and provides personalized alerts and intervention prompts to support both patients and clinicians. Throughout the intervention and 12-month follow-up, participants are monitored using biological tests like urine analysis and breath alcohol testing to verify substance use relapse. Researchers also assess withdrawal symptoms, cravings, emotional well-being, psychosocial functioning, relapse rates, and patient satisfaction. The study involves 150 adults and aims to provide evidence on how the digital tool can enhance addiction treatment protocols and long-term outcomes.